Cargando…

Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis

BACKGROUND/AIMS: The transmembrane proteins Neph1 and nephrin form a complex in the slit diaphragm (SD) of podocytes. As recent studies indicate an involvement of this complex in the polymerization of the actin cytoskeleton and proteinuria, we wanted to study the subcellular localization of Neph1 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulkko, Jenny, Patrakka, Jaakko, Lal, Mark, Tryggvason, Karl, Hultenby, Kjell, Wernerson, Annika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202611/
https://www.ncbi.nlm.nih.gov/pubmed/25404935
http://dx.doi.org/10.1159/000365091
_version_ 1782340323241885696
author Hulkko, Jenny
Patrakka, Jaakko
Lal, Mark
Tryggvason, Karl
Hultenby, Kjell
Wernerson, Annika
author_facet Hulkko, Jenny
Patrakka, Jaakko
Lal, Mark
Tryggvason, Karl
Hultenby, Kjell
Wernerson, Annika
author_sort Hulkko, Jenny
collection PubMed
description BACKGROUND/AIMS: The transmembrane proteins Neph1 and nephrin form a complex in the slit diaphragm (SD) of podocytes. As recent studies indicate an involvement of this complex in the polymerization of the actin cytoskeleton and proteinuria, we wanted to study the subcellular localization of Neph1 in the normal human kidney and its expression in focal segmental glomerulosclerosis (FSGS), minimal change nephrotic syndrome (MCNS), and the corresponding experimental models of Adriamycin-induced nephropathy (ADR) and puromycin aminonucleoside nephrosis (PAN). All these disorders are characterized by substantial foot process effacement (FPE) and proteinuria. MATERIALS AND METHODS: Kidney biopsies from patients with primary FSGS (perihilar type) and MCNS were compared to normal renal tissue. Mouse and rat kidney cortices from days 7 and 14 after Adriamycin injection and days 2 and 4 after puromycin aminonucleoside injection, respectively, were compared to control mouse and rat kidney. Polyclonal antibodies against Neph1 and nephrin were used for immunoelectron microscopy, and semiquantification was performed. RESULTS: We localized Neph1 mainly to, and in close proximity to, the SD. Double staining of Neph1 and nephrin showed the proteins to be in close connection in the SD. The total amount of Neph1 in the podocytes was significantly reduced in FSGS, MCNS, ADR, and PAN. The reduction of Neph1 was also seen in areas with and without FPE. Nephrin was reduced in MCNS and PAN but unchanged in FSGS. CONCLUSION: With nephrin (but not Neph1) unchanged in FSGS, there might be a disruption of the complex and an involvement of Neph1 in its pathogenesis.
format Online
Article
Text
id pubmed-4202611
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-42026112014-11-17 Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis Hulkko, Jenny Patrakka, Jaakko Lal, Mark Tryggvason, Karl Hultenby, Kjell Wernerson, Annika Nephron Extra Original Paper BACKGROUND/AIMS: The transmembrane proteins Neph1 and nephrin form a complex in the slit diaphragm (SD) of podocytes. As recent studies indicate an involvement of this complex in the polymerization of the actin cytoskeleton and proteinuria, we wanted to study the subcellular localization of Neph1 in the normal human kidney and its expression in focal segmental glomerulosclerosis (FSGS), minimal change nephrotic syndrome (MCNS), and the corresponding experimental models of Adriamycin-induced nephropathy (ADR) and puromycin aminonucleoside nephrosis (PAN). All these disorders are characterized by substantial foot process effacement (FPE) and proteinuria. MATERIALS AND METHODS: Kidney biopsies from patients with primary FSGS (perihilar type) and MCNS were compared to normal renal tissue. Mouse and rat kidney cortices from days 7 and 14 after Adriamycin injection and days 2 and 4 after puromycin aminonucleoside injection, respectively, were compared to control mouse and rat kidney. Polyclonal antibodies against Neph1 and nephrin were used for immunoelectron microscopy, and semiquantification was performed. RESULTS: We localized Neph1 mainly to, and in close proximity to, the SD. Double staining of Neph1 and nephrin showed the proteins to be in close connection in the SD. The total amount of Neph1 in the podocytes was significantly reduced in FSGS, MCNS, ADR, and PAN. The reduction of Neph1 was also seen in areas with and without FPE. Nephrin was reduced in MCNS and PAN but unchanged in FSGS. CONCLUSION: With nephrin (but not Neph1) unchanged in FSGS, there might be a disruption of the complex and an involvement of Neph1 in its pathogenesis. S. Karger AG 2014-09-19 /pmc/articles/PMC4202611/ /pubmed/25404935 http://dx.doi.org/10.1159/000365091 Text en Copyright © 2014 by S. Karger AG, Basel http://www.karger.com/Authors_Choice This is an open access article distributed under the terms of Karger's Author's Choice™ licensing agreement, adapted from the Creative Commons Attribution Non-Commercial 2.5 license. This license allows authors to re-use their articles for educational and research purposes as long as the author and the journal are fully acknowledged.
spellingShingle Original Paper
Hulkko, Jenny
Patrakka, Jaakko
Lal, Mark
Tryggvason, Karl
Hultenby, Kjell
Wernerson, Annika
Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
title Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
title_full Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
title_fullStr Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
title_full_unstemmed Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
title_short Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
title_sort neph1 is reduced in primary focal segmental glomerulosclerosis, minimal change nephrotic syndrome, and corresponding experimental animal models of adriamycin-induced nephropathy and puromycin aminonucleoside nephrosis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202611/
https://www.ncbi.nlm.nih.gov/pubmed/25404935
http://dx.doi.org/10.1159/000365091
work_keys_str_mv AT hulkkojenny neph1isreducedinprimaryfocalsegmentalglomerulosclerosisminimalchangenephroticsyndromeandcorrespondingexperimentalanimalmodelsofadriamycininducednephropathyandpuromycinaminonucleosidenephrosis
AT patrakkajaakko neph1isreducedinprimaryfocalsegmentalglomerulosclerosisminimalchangenephroticsyndromeandcorrespondingexperimentalanimalmodelsofadriamycininducednephropathyandpuromycinaminonucleosidenephrosis
AT lalmark neph1isreducedinprimaryfocalsegmentalglomerulosclerosisminimalchangenephroticsyndromeandcorrespondingexperimentalanimalmodelsofadriamycininducednephropathyandpuromycinaminonucleosidenephrosis
AT tryggvasonkarl neph1isreducedinprimaryfocalsegmentalglomerulosclerosisminimalchangenephroticsyndromeandcorrespondingexperimentalanimalmodelsofadriamycininducednephropathyandpuromycinaminonucleosidenephrosis
AT hultenbykjell neph1isreducedinprimaryfocalsegmentalglomerulosclerosisminimalchangenephroticsyndromeandcorrespondingexperimentalanimalmodelsofadriamycininducednephropathyandpuromycinaminonucleosidenephrosis
AT wernersonannika neph1isreducedinprimaryfocalsegmentalglomerulosclerosisminimalchangenephroticsyndromeandcorrespondingexperimentalanimalmodelsofadriamycininducednephropathyandpuromycinaminonucleosidenephrosis